MYO Company Profile and Key Details

MYO has shown mixed momentum, losing -0.52% over the past week and -4.86% over the past quarter, though year-to-date performance is up 7.68%. Short-term trend indicators are bullishly aligned (SMA20 -1.43%, SMA50 -12.77%, SMA200 -45.43%). The stock’s 14-day RSI is 45.7 (neutral), while the ATR of 0.07 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -87.61% below its high and over 21.78% above its low. Average 10-day trading volume of 402.53 thousand shares is below the 3-month average of 551.29 thousand, indicating normal recent market interest.

Myomo, Inc. has 38.44 million shares outstanding. The public float is 27.66 million shares, elevated short interest at 12.93% of float. This equals 4.77 million shares. The short ratio is 10.12 days. Institutional investors hold 71.27% of the float. Insiders own 7.01%. GUDONIS PAUL R holds 1.26 million shares, KIRK THOMAS F has 481.86 thousand shares and HENRY DAVID A has 352.19 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Myomo, Inc. generated EPS of -$0.29 over the past year. Five-year average earnings growth is 62.04%. Wall Street analysts project EPS growth of -4.96% annually over the next five years. The latest quarter delivered EPS of -$0.09. The next quarter is forecast at -$0.09. Next year's EPS is expected at $37.50. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 7 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $11.00 to $5.00. The high target offers 1275.0% upside. The low target suggests 525.0% downside. The mean target is $9.36. This offers 1070.0% upside. Myomo, Inc. earnings surprise history is a mixed track record. The quarter that ended November 10, 2025, missed forecasts by -21.04%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include -57.13% in August 06, 2024.

Myomo, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.88. This means the shares are trading below this model’s fair value.

Myomo, Inc. (AMEX:MYO) closed at $0.81 USD, gaining $0.01 (1.29%) from the previous close of $0.80. The stock is currently mid-range between its 52-week high and low $0.64 and $6.30. With a market capitalization of about $31.18 million, Myomo, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.13). Key stats such as the average daily volume over the past year has been around 531.13 thousand shares, in line with its 52-week average. Headquartered in Burlington, MA, Myomo, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Paul R. Gudonis, the company employs approximately 184 people and listed since June 12, 2017. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States.

Myomo, Inc. trades at a P/E ratio of -2.79, slightly below the S&P 500 average, with a price-to-sales ratio of 0.74 and a price-to-book ratio of 2.3 suggesting the stock is closer to book value. The P/FCF stands at -2.21, also below market averages.

Myomo, Inc. (AMEX:MYO) shares are flat 7.68% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Myomo, Inc. trading at a premium to the broader market with a P/E of -2.79. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.24, suggesting 928.71% upside. Our AI forecast model points to short-term weakness (-8.86% over two weeks), a medium-term fall (-51.31% over three months), and a longer-term loss (-55.06% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Myomo, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -8.86%, with price expected at $0.73 by March 20, 2026, within a range of $0.68 to $0.77 3-Month Outlook: Projected fall of -51.31%, reaching $0.39 by June 04, 2026, with a range of $0.30 to $0.48. 1-Year Outlook: Projected loss of -55.06%, with price at $0.36 by March 05, 2027, within a range of $0.00 to $0.00.